Hope for Alzheimer`s patients? Dipeptide blocks the formation of toxic amyloid β-peptide aggregates in mice
Thursday, December 4, 2008 - 12:37
in Health & Medicine
(PhysOrg.com) -- Alzheimer's disease is the primary cause of age-related dementia. About 15 million people are affected by this neurodegenerative disease worldwide. It has so far not been possible to combat the causes of Alzheimer`s disease. Israeli researchers have now developed a novel approach for treatment. As they report in the journal Angewandte Chemie, the new drug, a molecule made from two nonphysiological amino acids, improves the cognitive abilities of mice with Alzheimer`s and reduces the amyloid plaques in their brains.
Read the whole article on Physorg
More from Physorg
Related
- A variant form of amyloid beta hinders amyloidogenesis and the development of Alzheimer's diseaseThu, 12 Mar 2009, 15:29:32 EDT
- Scientists remove amyloid plaques from brains of live animals with Alzheimer's diseaseThu, 15 Oct 2009, 9:37:38 EDT
- MGH study suggests how amyloid plaques may damage brain cells in Alzheimer's diseaseWed, 30 Jul 2008, 12:29:03 EDT
- How the APOE gene can modify your risk for Alzheimer's diseaseThu, 13 Nov 2008, 17:37:41 EST
- Structural polymorphism of 441-residue Tau at single residue resolutionTue, 17 Feb 2009, 15:57:10 EST